NIH-funded research R01 grant

Investigating how specific signaling pathways affect insulin production in diabetes

Official title: The role of G protein-dependent and -independent EP3 signaling in beta-cell compensation and diabetes

Funded at University of Wisconsin-Madison · NIH-11075871 · Data updated 2026-11-12

This study is looking at how specific signals in the cells that make insulin can help improve insulin production and increase the number of healthy insulin-producing cells, which could lead to better treatments for people with type 2 diabetes.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Wisconsin-Madison
NIH-funded
Lab location1 site (Madison, United States)
Project startApril 18, 2024
Project endMarch 31, 2028
Funding year2025
Award (this year)$613,302
NIH project number5R01DK137505-02
Project IDNIH-11075871 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with type 2 diabetes, particularly those who may not respond well to current treatments.

Less likely to help

Patients with type 1 diabetes or those whose diabetes is not linked to beta-cell dysfunction may not benefit from this research.

What this research studies

This research focuses on understanding the role of certain signaling pathways in pancreatic beta-cells, which are crucial for insulin production. By examining the effects of the EP3 receptor and its associated G protein, the study aims to identify new methods to enhance insulin secretion and increase the number of functional beta-cells in individuals with type 2 diabetes. The approach involves both cellular and molecular techniques to explore how these pathways can be targeted for better diabetes treatment. Patients may benefit from potential new therapies that improve insulin function and overall glucose management.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that enhance insulin production and improve blood sugar control in diabetes patients.

How similar studies have gone: Previous research has shown promising results in targeting similar signaling pathways to improve beta-cell function, indicating potential for success in this approach.

Where this research is happening

  • University of Wisconsin-Madison
    Madison, United States
    Active

Researchers

  • Principal investigator: Kimple, Michelle E — University of Wisconsin-Madison
  • Study coordinator: Kimple, Michelle E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.